Latest Insider Transactions at Uni Qure N.V. (QURE)
This section provides a real-time view of insider transactions for Uni Qure N.V. (QURE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of uniQure N.V. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of uniQure N.V.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 26
2024
|
Walid Abi Saab Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,447
-1.24%
|
$5,788
$4.36 P/Share
|
|
Jun 19
2024
|
Jeremy P. Springhorn Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,080
+20.24%
|
-
|
|
Jun 19
2024
|
Robert Gut Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,080
+13.39%
|
-
|
|
Jun 19
2024
|
David D. Meek Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,080
+22.19%
|
-
|
|
Jun 19
2024
|
Madhavan Balachandran Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,080
+20.24%
|
-
|
|
Jun 19
2024
|
Leonard E Post Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,080
+25.13%
|
-
|
|
Jun 19
2024
|
Jack Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,080
+35.66%
|
-
|
|
Jun 19
2024
|
Rachelle Suzanne Jacques Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,080
+26.43%
|
-
|
|
Jun 17
2024
|
Pierre Caloz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,936
-2.47%
|
$11,744
$4.81 P/Share
|
|
Jun 17
2024
|
Christian Klemt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,611
-0.97%
|
$6,444
$4.8 P/Share
|
|
Jun 13
2024
|
Leonard E Post Director |
SELL
Open market or private sale
|
Direct |
2,222
-12.19%
|
$11,110
$5.14 P/Share
|
|
Jun 13
2024
|
Jeannette Potts Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,781
-4.95%
|
$19,124
$4.98 P/Share
|
|
Jun 13
2024
|
Jeremy P. Springhorn Director |
SELL
Open market or private sale
|
Direct |
2,231
-8.59%
|
$11,155
$5.12 P/Share
|
|
Jun 13
2024
|
David D. Meek Director |
SELL
Open market or private sale
|
Direct |
2,229
-9.92%
|
$11,145
$5.12 P/Share
|
|
Jun 13
2024
|
Madhavan Balachandran Director |
SELL
Open market or private sale
|
Direct |
2,231
-8.58%
|
$11,155
$5.12 P/Share
|
|
Jun 13
2024
|
Paula Soteropoulos Director |
SELL
Open market or private sale
|
Direct |
2,220
-9.9%
|
$11,100
$5.14 P/Share
|
|
Jun 13
2024
|
Jack Kaye Director |
SELL
Open market or private sale
|
Direct |
2,218
-25.44%
|
$11,090
$5.16 P/Share
|
|
Jun 13
2024
|
Robert Gut Director |
SELL
Open market or private sale
|
Direct |
3,504
-7.35%
|
$17,520
$5.12 P/Share
|
|
Jun 13
2024
|
Rachelle Suzanne Jacques Director |
SELL
Open market or private sale
|
Direct |
2,221
-13.36%
|
$11,105
$5.14 P/Share
|
|
Mar 01
2024
|
Matthew C Kapusta CEO, Managing Director |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+20.25%
|
-
|
|
Mar 01
2024
|
Walid Abi Saab Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,500
+29.78%
|
-
|
|
Mar 01
2024
|
Christian Klemt Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,500
+22.92%
|
-
|
|
Mar 01
2024
|
Pierre Caloz Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,000
+21.76%
|
-
|
|
Mar 01
2024
|
Jeannette Potts Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,500
+33.88%
|
-
|
|
Feb 26
2024
|
Pierre Caloz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,455
-9.94%
|
$56,730
$6.47 P/Share
|
|
Feb 26
2024
|
Christian Klemt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,906
-11.97%
|
$95,436
$6.38 P/Share
|
|
Feb 26
2024
|
Matthew C Kapusta CEO, Managing Director |
SELL
Open market or private sale
|
Direct |
27,904
-5.95%
|
$167,424
$6.35 P/Share
|
|
Sep 18
2023
|
Ricardo Dolmetsch President, R&D |
SELL
Open market or private sale
|
Direct |
5,841
-3.45%
|
$40,887
$7.46 P/Share
|
|
Jul 10
2023
|
Pierre Caloz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
15,117
-13.72%
|
$166,287
$11.36 P/Share
|
|
Jun 16
2023
|
Paula Soteropoulos Director |
SELL
Open market or private sale
|
Direct |
2,275
-9.21%
|
$40,950
$18.99 P/Share
|
|
Jun 16
2023
|
Rachelle Suzanne Jacques Director |
SELL
Open market or private sale
|
Direct |
2,301
-12.16%
|
$41,418
$18.76 P/Share
|
|
Jun 16
2023
|
David D. Meek Director |
SELL
Open market or private sale
|
Direct |
2,290
-9.24%
|
$41,220
$18.85 P/Share
|
|
Jun 16
2023
|
Leonard E Post Director |
SELL
Open market or private sale
|
Direct |
2,291
-11.17%
|
$41,238
$18.83 P/Share
|
|
Jun 16
2023
|
Robert Gut Director |
SELL
Open market or private sale
|
Direct |
3,228
-6.34%
|
$58,104
$18.88 P/Share
|
|
Jun 16
2023
|
Jack Kaye Director |
SELL
Open market or private sale
|
Direct |
2,280
-6.26%
|
$41,040
$18.93 P/Share
|
|
Jun 16
2023
|
Pierre Caloz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,920
-2.58%
|
$52,560
$18.8 P/Share
|
|
Jun 16
2023
|
Madhavan Balachandran Director |
SELL
Open market or private sale
|
Direct |
2,283
-8.07%
|
$41,094
$18.91 P/Share
|
|
Jun 16
2023
|
Christian Klemt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,587
-1.18%
|
$28,566
$18.94 P/Share
|
|
Jun 16
2023
|
Jeremy P. Springhorn Director |
SELL
Open market or private sale
|
Direct |
2,286
-8.09%
|
$41,148
$18.88 P/Share
|
|
Jun 13
2023
|
Paula Soteropoulos Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,700
+26.05%
|
-
|
|
Jun 13
2023
|
Rachelle Suzanne Jacques Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,700
+31.49%
|
-
|
|
Jun 13
2023
|
David D. Meek Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,700
+25.99%
|
-
|
|
Jun 13
2023
|
Leonard E Post Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,700
+29.78%
|
-
|
|
Jun 13
2023
|
Robert Gut Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,700
+14.6%
|
-
|
|
Jun 13
2023
|
Jack Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,700
+19.29%
|
-
|
|
Jun 13
2023
|
Madhavan Balachandran Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,700
+23.53%
|
-
|
|
Jun 13
2023
|
Jeremy P. Springhorn Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,700
+23.53%
|
-
|
|
Jun 13
2023
|
Jeannette Potts Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,100
+50.0%
|
-
|
|
Mar 07
2023
|
Pierre Caloz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
990
-0.87%
|
$20,790
$21.33 P/Share
|
|
Mar 07
2023
|
Alexander Edward Kuta Iii Executive VP, Operations |
SELL
Open market or private sale
|
Direct |
585
-0.64%
|
$12,285
$21.36 P/Share
|